歯周病治療市場：治療タイプ、製品タイプ、患者タイプ、エンドユーザー別-2025～2030年の世界予測

歯周病治療市場は、2024年には24億7,000万米ドルとなり、2025年には26億米ドル、CAGR 5.49%で成長し、2030年には34億1,000万米ドルに達すると予測されています。

急速に進化する今日のヘルスケア環境において、歯周病治療は革新的な方法論と新たな臨床手法によって大きな進歩を遂げています。歯周病治療の臨床的側面と患者中心の側面の両方に対応するための調査と技術的進化が融合し、市場は大幅な変貌を遂げています。現代の治療オプションは、患者の不快感を最小限に抑え、長期的な合併症を軽減しながら治療結果を改善しようとする多様な治療法を包含しています。本レポートでは、現在の市場動向を包括的に概観し、高度な技術の統合、製品の革新、非外科的治療と外科的治療の両方に対する需要の高まりに焦点を当てています。歯周病の有病率が世界的に上昇を続ける中、これらの開発と治療法の選択に影響を与える根本的な要因を理解することは、意思決定者や業界の専門家にとって同様に必須となります。本レポートでは、今日の市場を形成している変革的な変化、詳細なセグメンテーションの洞察、地域別の成長促進要因、主要な業界プレーヤーについて解説します。このエグゼクティブサマリーは、厳密な分析と戦略的な先見性をバランスよく融合させることで、歯周病管理の複雑さを乗り越えつつ、将来の機会を生かそうとする利害関係者にとって重要な資料となります。

歯周病治療市場の変革

歯周病治療市場は、患者中心の技術主導型治療への広範な傾向を裏付けるような変革的な動向を経験しています。技術革新は従来のアプローチを再構築するだけでなく、複雑な歯周病状態を管理するための改善されたツールや方法論を臨床医に提供しています。診断技術、治療計画、およびデジタル支援処置の進歩は、開業医が予防治療と積極的介入の両方にアプローチする方法のパラダイムシフトにつながっています。高精度のレーザー治療や低侵襲の外科技術の導入は、全体的な治療経験を向上させながら、患者の回復時間を短縮しています。さらに、進化するヘルスケア政策と予防医学への関心の高まりが、侵襲性の低い治療オプションへの強い需要を刺激しています。臨床調査により、従来のスケーリングとルートプランニングを最先端のレーザー治療と組み合わせることの有効性が強調され続けているため、市場は、科学的なブレークスルーを実際の応用に結びつける適応的な変化を目の当たりにしています。この戦略的転換は、学際的な協力関係によってさらに後押しされ、歯周治療における標準治療を再定義するための集団的努力を推進しています。エビデンスに基づく治療の重視とイノベーションへのコミットメントが相まって、市場内の大幅な再編成に拍車がかかり、医療提供者と業界リーダーの双方に、よりダイナミックで結果重視の戦略を優先して従来の治療プロトコルを再評価するよう促しています。

歯周病治療市場の主なセグメンテーション洞察

市場セグメンテーションを深く掘り下げると、歯周病治療の多様なニーズを理解するのに役立つ多面的なアプローチが明らかになります。治療タイプに基づくセグメンテーションから得られる洞察は、非外科的介入と外科的介入の明確な区別を示しています。非外科的治療では、抗生物質や抗菌薬の使用、レーザー治療、スケーリング・ルートプレーニングなどが行われ、これらは保存的歯周治療の基礎となります。これと並行して、外科的治療（骨移植、フラップ手術、誘導組織再生など）は、組織の修復と再生が最も重要な、より高度な症例に対応します。さらに、製品タイプに基づくセグメンテーションは、市場を装置、薬剤、再生材料に分けることで分析を強化します。具体的には、機器にはレーザー機器、スケーラー、カッター、超音波機器が含まれ、薬剤には抗生物質から防腐剤チップ、非ステロイド性抗炎症薬までが含まれ、再生材料には骨充填剤、コラーゲン膜、成長因子が含まれます。患者タイプ別セグメンテーションでは、成人、老人、小児患者を区別することで市場分析をさらに精緻化し、人口統計学特有のニーズや動向に関するテーラーメイドの洞察を提供します。エンドユーザー別のセグメンテーションでは、学術・研究機関から外来手術センター、歯科クリニック、在宅ケア環境、病院まで、幅広いケア環境を把握することで、包括的な視野をさらに絞り込みます。このような多様なセグメンテーションの枠組みは、変化する需要パターンを理解し、歯周治療イノベーションの将来の軌道を予測する上で非常に重要です。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で美容歯周治療の需要が増加
    • 定期的な歯科検診と歯周病治療を奨励する政府と保険のインセンティブ
  • 抑制要因
    • 歯周病に伴う高額な治療費
  • 機会
    • 歯周病治療手法の革新に向けた学術機関との継続的な共同活動
    • 歯科診療における人工知能の統合による個別歯周病治療計画
  • 課題
    • 歯周病分野における知的財産権の課題と特許保護に関する懸念
• 市場セグメンテーション分析
  • 治療の種類：患者の不快感を最小限に抑え、回復時間を短縮できるため、非外科的治療の採用が増加しています。
  • 歯周病治療市場の比較分析：歯科医院、病院、在宅ケアの現場におけるエンドユーザーセグメントをターゲットにした戦略
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 歯周病治療市場治療の種類別

• 非外科的治療
  • 抗生物質と抗菌剤
  • レーザー治療
  • スケーリングとルートプレーニング
• 外科的治療
  • 骨移植
  • 皮弁手術
  • 誘導組織再生

第7章 歯周病治療市場：製品タイプ別

• デバイス
  • レーザーデバイス
  • スケーラーとカッター
  • 超音波装置
• 医薬品
  • 抗生物質
  • 消毒チップ
  • 非ステロイド性抗炎症薬
• 再生材料
  • 骨充填剤
  • コラーゲン膜
  • 成長因子

第8章 歯周病治療市場患者タイプ別

• 大人
• 高齢者
• 小児科

第9章 歯周病治療市場：エンドユーザー別

• 学術調査機関
• 外来手術センター
• 歯科医院
• ホームケア設定
• 病院

第10章 南北アメリカの歯周病治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の歯周病治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの歯周病治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• ACTEON Group
• Bausch Health Companies Inc.
• Becton, Dickinson and Company
• BioHorizons, Inc.
• Colgate-Palmolive Company
• Den-Mat Holdings, LLC
• Dentsply Sirona Inc.
• GC Corporation
• Geistlich Pharma AG
• GlaxoSmithKline plc
• Haleon group
• Henry Schein, Inc.
• Ivoclar Vivadent AG
• Johnson & Johnson
• Kuraray Noritake Dental Inc.
• Lion Corporation
• Mectron S.p.A.
• Patterson Companies, Inc.
• Pfizer Inc.
• Procter & Gamble Company
• Septodont Holding SAS
• Shofu Dental Corporation
• Straumann Group
• Sunstar Suisse SA
• TePe Oral Health Care, Inc.
• Ultradent Products, Inc.
• VOCO GmbH
• Water Pik, Inc.
• Zimmer Biomet Dental

LIST OF FIGURES

• FIGURE 1. PERIODONTAL DISEASE TREATMENT MARKET MULTI-CURRENCY
• FIGURE 2. PERIODONTAL DISEASE TREATMENT MARKET MULTI-LANGUAGE
• FIGURE 3. PERIODONTAL DISEASE TREATMENT MARKET RESEARCH PROCESS
• FIGURE 4. PERIODONTAL DISEASE TREATMENT MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. PERIODONTAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. PERIODONTAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. PERIODONTAL DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PERIODONTAL DISEASE TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS & ANTIMICROBIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SCALING & ROOT PLANING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY BONE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY FLAP SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY GUIDED TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SCALERS & CUTTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY ULTRASONIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY ANTISEPTIC CHIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY BONE FILLERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COLLAGEN MEMBRANES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. CANADA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CANADA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 74. CANADA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 75. CANADA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. CANADA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. CANADA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 78. CANADA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 79. CANADA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. CANADA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. CHINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. CHINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 121. CHINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 122. CHINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. CHINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. CHINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 125. CHINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 126. CHINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. CHINA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. INDIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. INDIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 130. INDIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 131. INDIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. INDIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 133. INDIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 134. INDIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 135. INDIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. INDIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. INDONESIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 142. INDONESIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 144. INDONESIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 149. JAPAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. JAPAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. JAPAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 152. JAPAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 153. JAPAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 156. MALAYSIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 157. MALAYSIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 158. MALAYSIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. MALAYSIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. MALAYSIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 161. MALAYSIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 162. MALAYSIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. PHILIPPINES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 166. PHILIPPINES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 167. PHILIPPINES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. PHILIPPINES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. PHILIPPINES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 170. PHILIPPINES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 171. PHILIPPINES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. PHILIPPINES PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SINGAPORE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SINGAPORE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 175. SINGAPORE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 176. SINGAPORE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SINGAPORE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. SINGAPORE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 179. SINGAPORE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 180. SINGAPORE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. SINGAPORE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. SOUTH KOREA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. SOUTH KOREA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH KOREA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 185. SOUTH KOREA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. SOUTH KOREA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. SOUTH KOREA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 188. SOUTH KOREA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 189. SOUTH KOREA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. SOUTH KOREA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. TAIWAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. TAIWAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 193. TAIWAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 194. TAIWAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 195. TAIWAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. TAIWAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 197. TAIWAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 198. TAIWAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 199. TAIWAN PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. THAILAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. THAILAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 202. THAILAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 203. THAILAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. THAILAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. THAILAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 206. THAILAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 207. THAILAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 208. THAILAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. VIETNAM PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 210. VIETNAM PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 211. VIETNAM PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 212. VIETNAM PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 213. VIETNAM PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. VIETNAM PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 215. VIETNAM PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 216. VIETNAM PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 217. VIETNAM PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 228. DENMARK PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 229. DENMARK PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 230. DENMARK PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 231. DENMARK PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. DENMARK PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 233. DENMARK PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 234. DENMARK PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 235. DENMARK PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 236. DENMARK PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. EGYPT PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 238. EGYPT PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 239. EGYPT PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 240. EGYPT PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 241. EGYPT PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 242. EGYPT PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 243. EGYPT PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 244. EGYPT PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 245. EGYPT PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. FINLAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 247. FINLAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 248. FINLAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 249. FINLAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 250. FINLAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 251. FINLAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 253. FINLAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 254. FINLAND PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 255. FRANCE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 256. FRANCE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 257. FRANCE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 258. FRANCE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 259. FRANCE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 260. FRANCE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 262. FRANCE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 263. FRANCE PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 264. GERMANY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 265. GERMANY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 266. GERMANY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 267. GERMANY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 268. GERMANY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 269. GERMANY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 271. GERMANY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 272. GERMANY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 273. ISRAEL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 274. ISRAEL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 275. ISRAEL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 276. ISRAEL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 277. ISRAEL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 278. ISRAEL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 279. ISRAEL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 280. ISRAEL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 281. ISRAEL PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 282. ITALY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 283. ITALY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 284. ITALY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 285. ITALY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 286. ITALY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 287. ITALY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 288. ITALY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 289. ITALY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 290. ITALY PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 291. NETHERLANDS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 292. NETHERLANDS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 293. NETHERLANDS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 294. NETHERLANDS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 295. NETHERLANDS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 296. NETHERLANDS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 297. NETHERLANDS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 298. NETHERLANDS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 299. NETHERLANDS PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 300. NIGERIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 301. NIGERIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY NON-SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 302. NIGERIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
• TABLE 303. NIGERIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 304. NIGERIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 305. NIGERIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 306. NIGERIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY REGENERATIVE MATERIALS, 2018-2030 (USD MILLION)
• TABLE 307. NIGERIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 308. NIGERIA PERIODONTAL DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILL

The Periodontal Disease Treatment Market was valued at USD 2.47 billion in 2024 and is projected to grow to USD 2.60 billion in 2025, with a CAGR of 5.49%, reaching USD 3.41 billion by 2030.

In today's rapidly evolving healthcare environment, periodontal disease treatment is witnessing significant advancements driven by innovative methodologies and emerging clinical practices. The market has undergone a substantial transformation as research and technological evolution converge to address both the clinical and patient-centric aspects of periodontal care. Modern treatment options now encompass a diverse range of therapies that seek to improve outcomes while minimizing patient discomfort and reducing long-term complications. This report provides a comprehensive overview of current market trends, highlighting the integration of advanced techniques, product innovations, and the increasing demand for both non-surgical and surgical interventions. As the prevalence of periodontal disease continues to rise globally, understanding these developments and the underlying factors influencing therapeutic choices becomes imperative for decision-makers and industry experts alike. The narrative that follows delves into transformative shifts, detailed segmentation insights, regional growth drivers, and key industry players shaping the market today. Through a balanced amalgamation of rigorous analysis and strategical foresight, this executive summary serves as a vital resource for stakeholders looking to navigate the complexities of periodontal disease management while capitalizing on future opportunities.

Transformative Shifts in the Periodontal Treatment Landscape

The periodontal disease treatment market is experiencing transformative shifts that underscore a broader trend towards patient-centric and technologically driven care. Innovations are not only reshaping traditional approaches but are also providing clinicians with improved tools and methodologies to manage complex periodontal conditions. Advances in diagnostic technologies, treatment planning, and digitally-assisted procedures have led to a paradigm shift in how practitioners approach both preventive care and active intervention. The introduction of high-precision laser treatments and minimally invasive surgical techniques has reduced patient recovery times while enhancing the overall treatment experience. Furthermore, evolving healthcare policies and an increased focus on preventive medicine are stimulating a robust demand for less invasive treatment options. As clinical research continues to highlight the efficacy of combining traditional scaling and root planning with cutting edge laser therapy, the market is witnessing an adaptive transformation that bridges scientific breakthroughs with real-world application. This strategic shift is further supported by interdisciplinary collaborations, driving a collective effort to redefine standards of care in periodontal treatment. The emphasis on evidence-based practice combined with a commitment to innovation has spurred significant restructuring within the market, urging both providers and industry leaders to reevaluate traditional treatment protocols in favor of more dynamic, results-oriented strategies.

Key Segmentation Insights in the Periodontal Treatment Market

A deep dive into market segmentation reveals a multifaceted approach that is instrumental in understanding the diverse needs of the periodontal treatment landscape. Insights derived from segmentation based on treatment type illustrate clear distinctions between non-surgical and surgical interventions. Under the non-surgical category, therapy is further refined through the application of antibiotics and antimicrobials, laser therapy, as well as scaling and root planing, which collectively form the cornerstone of conservative periodontal care. In parallel, surgical treatments-including bone grafting, flap surgery, and guided tissue regeneration-cater to more advanced cases where tissue repair and regeneration are paramount. Additionally, segmentation based on product type enhances this analysis by dividing the market into devices, medications, and regenerative materials. Specifically, devices encompass laser devices, scalers and cutters, as well as ultrasonic devices; medications cover the spectrum from antibiotics to antiseptic chips and non-steroidal anti-inflammatory drugs; and regenerative materials are typified by bone fillers, collagen membranes, and growth factors. The patient type segmentation further refines market analysis by differentiating between adult, geriatric, and pediatric patients, offering tailored insights into demographic-specific needs and trends. The segmentation by end-user refines this comprehensive view by capturing a broad spectrum of care settings that range from academic and research institutes to ambulatory surgical centers, dental clinics, homecare settings, and hospitals. Such a diversified segmentation framework is critical in understanding shifting demand patterns and anticipating the future trajectory of periodontal treatment innovations.

Based on Treatment Type, market is studied across Non-Surgical Treatment and Surgical Treatment. The Non-Surgical Treatment is further studied across Antibiotics & Antimicrobials, Laser Therapy, and Scaling & Root Planing. The Surgical Treatment is further studied across Bone Grafting, Flap Surgery, and Guided Tissue Regeneration.

Based on Product Type, market is studied across Devices, Medications, and Regenerative Materials. The Devices is further studied across Laser Devices, Scalers & Cutters, and Ultrasonic Devices. The Medications is further studied across Antibiotics, Antiseptic Chips, and Non-steroidal Anti-inflammatory Drugs. The Regenerative Materials is further studied across Bone Fillers, Collagen Membranes, and Growth Factors.

Based on Patient Type, market is studied across Adults, Geriatric, and Pediatric.

Based on End-User, market is studied across Academic & Research Institutes, Ambulatory Surgical Centers, Dental Clinics, Homecare Settings, and Hospitals.

Regional Dynamics Shaping the Global Market

The geographical landscape of the periodontal treatment market is characterized by distinct regional trends, each contributing uniquely to the overall market dynamics. In the Americas, robust healthcare infrastructure and a heightened emphasis on preventive oral care have driven significant market growth, setting high benchmarks in clinical excellence. In contrast, Europe, the Middle East, and Africa are marked by a blend of traditional practices and progressive treatment modalities where evolving regulatory frameworks and increasing investment in research and development are creating new opportunities. Meanwhile, the Asia-Pacific region is rapidly emerging as a critical player, with expanding urbanization, increasing awareness about dental health, and a burgeoning middle class fueling demand for advanced periodontal care. This regional diversity underscores the importance of tailoring strategies to meet local market needs while also leveraging global best practices. The interplay between established markets and emerging economies continues to define the competitive environment, offering nuanced insights into how demographic shifts, economic growth, and technological adoption collectively influence regional performance in periodontal disease treatment.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights into Leading Industry Players

An in-depth look at the competitive landscape reveals a vibrant ecosystem of established and emerging companies that are driving innovation and setting industry standards in periodontal disease treatment. Prominent players such as 3M Company, ACTEON Group, Bausch Health Companies Inc., and Becton, Dickinson and Company are leading the way in product innovation and clinical excellence. Meanwhile, companies like BioHorizons, Inc. and Colgate-Palmolive Company have strengthened their market presence by integrating cutting-edge research with diversified product offerings. Other key contributors include Den-Mat Holdings, LLC, Dentsply Sirona Inc., and GC Corporation, who are noted for their commitment to enhancing patient outcomes through quality-driven solutions. Esteemed organizations such as Geistlich Pharma AG, GlaxoSmithKline plc, Haleon group, and Henry Schein, Inc. further complement the competitive matrix with robust portfolios and strategic market insights. Industry trailblazers like Ivoclar Vivadent AG, Johnson & Johnson, Kuraray Noritake Dental Inc., Lion Corporation, and Mectron S.p.A. continue to set benchmarks with innovative approaches, while the market dynamics are further enriched by the contributions of Patterson Companies, Inc., Pfizer Inc., Procter & Gamble Company, Septodont Holding SAS, Shofu Dental Corporation, Straumann Group, Sunstar Suisse SA, TePe Oral Health Care, Inc., Ultradent Products, Inc., VOCO GmbH, Water Pik, Inc., and Zimmer Biomet Dental. Collectively, this diverse group of companies fortifies the market with a blend of technological advancements, wide-ranging product portfolios, and unparalleled expertise in addressing the ever-evolving challenges of periodontal care.

The report delves into recent significant developments in the Periodontal Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ACTEON Group, Bausch Health Companies Inc., Becton, Dickinson and Company, BioHorizons, Inc., Colgate-Palmolive Company, Den-Mat Holdings, LLC, Dentsply Sirona Inc., GC Corporation, Geistlich Pharma AG, GlaxoSmithKline plc, Haleon group, Henry Schein, Inc., Ivoclar Vivadent AG, Johnson & Johnson, Kuraray Noritake Dental Inc., Lion Corporation, Mectron S.p.A., Patterson Companies, Inc., Pfizer Inc., Procter & Gamble Company, Septodont Holding SAS, Shofu Dental Corporation, Straumann Group, Sunstar Suisse SA, TePe Oral Health Care, Inc., Ultradent Products, Inc., VOCO GmbH, Water Pik, Inc., and Zimmer Biomet Dental. Actionable Recommendations for Industry Leaders

The evolving market trends in periodontal disease treatment underscore several strategic imperatives for industry leaders. A critical recommendation is to invest in continuous research and development to drive the discovery and adoption of innovative treatment protocols that not only enhance patient outcomes but also optimize clinical workflows. Leaders should consider leveraging data-driven insights to tailor their product and service offerings more effectively, ensuring that both non-surgical and surgical treatment options meet the nuanced demands of diverse patient demographics. Collaborations with academic and research institutions and strategic partnerships with technology providers can catalyze the integration of emerging therapies and digital health solutions into standard practice. Additionally, there is a growing need to prioritize educational initiatives that highlight the benefits and safe application of advanced periodontal treatments. This approach will help in building trust among healthcare providers and patients alike. Furthermore, streamlining regulatory compliance and reinforcing post-market data analytics can provide valuable feedback mechanisms, allowing companies to refine their products continually. Industry stakeholders are encouraged to harness these insights to create robust, scalable strategies that align with real-time market needs and future growth projections, thereby ensuring sustainable competitive advantage in a dynamic healthcare environment.

Conclusion: Steering Towards a Future of Innovation and Growth

In conclusion, the periodontal disease treatment market is undergoing a transformative phase characterized by technological innovations, dynamic segmentation strategies, and robust regional growth patterns. The integration of advanced treatment modalities, patient-specific strategies, and a wealth of clinical data has paved the way for significant advancements in both non-surgical and surgical periodontal care. Moreover, a detailed exploration of key regional trends and the competitive landscape underscores the critical importance of strategic collaborations, research investments, and market education. These elements are all essential in ensuring that providers not only meet current clinical challenges but also adapt to future opportunities. As industry players continue to push the envelope on treatment innovations and operational excellence, a forward-thinking approach is paramount to achieving sustainable growth and improved patient outcomes in periodontal care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for cosmetic periodontal procedures globally
    • 5.1.1.2. Government and insurance incentives encouraging regular dental check-ups and periodontal care
  • 5.1.2. Restraints
    • 5.1.2.1. High treatment costs associated with periodontal disease
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing collaborative activities with academic institutions for innovation in periodontal disease treatment methods
    • 5.1.3.2. Integration of artificial intelligence in dental practices for personalized periodontal treatment plans
  • 5.1.4. Challenges
    • 5.1.4.1. Concern associated with intellectual property challenges and patent protections within the periodontal field
• 5.2. Market Segmentation Analysis
  • 5.2.1. Treatment Type: Increasing adoption of non-surgical treatments due to their minimization of patient discomfort and faster recovery times
  • 5.2.2. Comparative analysis of periodontal treatment market: strategies targeting end-user segments in dental clinics, hospitals, and homecare settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Periodontal Disease Treatment Market, by Treatment Type

• 6.1. Introduction
• 6.2. Non-Surgical Treatment
  • 6.2.1. Antibiotics & Antimicrobials
  • 6.2.2. Laser Therapy
  • 6.2.3. Scaling & Root Planing
• 6.3. Surgical Treatment
  • 6.3.1. Bone Grafting
  • 6.3.2. Flap Surgery
  • 6.3.3. Guided Tissue Regeneration

7. Periodontal Disease Treatment Market, by Product Type

• 7.1. Introduction
• 7.2. Devices
  • 7.2.1. Laser Devices
  • 7.2.2. Scalers & Cutters
  • 7.2.3. Ultrasonic Devices
• 7.3. Medications
  • 7.3.1. Antibiotics
  • 7.3.2. Antiseptic Chips
  • 7.3.3. Non-steroidal Anti-inflammatory Drugs
• 7.4. Regenerative Materials
  • 7.4.1. Bone Fillers
  • 7.4.2. Collagen Membranes
  • 7.4.3. Growth Factors

8. Periodontal Disease Treatment Market, by Patient Type

• 8.1. Introduction
• 8.2. Adults
• 8.3. Geriatric
• 8.4. Pediatric

9. Periodontal Disease Treatment Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Ambulatory Surgical Centers
• 9.4. Dental Clinics
• 9.5. Homecare Settings
• 9.6. Hospitals

10. Americas Periodontal Disease Treatment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Periodontal Disease Treatment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Periodontal Disease Treatment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. HuFriedyGroup unveils Sterify Gel's antibiotic-free mucoadhesive approach to periodontal healing
  • 13.3.2. Oral Biolife's newly announces Ambrilux Dental Gel
  • 13.3.3. The FDA's approval of the UW Department of Oral Health Sciences to study rapamycin
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. ACTEON Group
• 3. Bausch Health Companies Inc.
• 4. Becton, Dickinson and Company
• 5. BioHorizons, Inc.
• 6. Colgate-Palmolive Company
• 7. Den-Mat Holdings, LLC
• 8. Dentsply Sirona Inc.
• 9. GC Corporation
• 10. Geistlich Pharma AG
• 11. GlaxoSmithKline plc
• 12. Haleon group
• 13. Henry Schein, Inc.
• 14. Ivoclar Vivadent AG
• 15. Johnson & Johnson
• 16. Kuraray Noritake Dental Inc.
• 17. Lion Corporation
• 18. Mectron S.p.A.
• 19. Patterson Companies, Inc.
• 20. Pfizer Inc.
• 21. Procter & Gamble Company
• 22. Septodont Holding SAS
• 23. Shofu Dental Corporation
• 24. Straumann Group
• 25. Sunstar Suisse SA
• 26. TePe Oral Health Care, Inc.
• 27. Ultradent Products, Inc.
• 28. VOCO GmbH
• 29. Water Pik, Inc.
• 30. Zimmer Biomet Dental